Neovasc Inc. T.NVC

Primary Symbol: NVCN

Healthcare Medical Instruments & Supplies

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

NDAQ:NVCN - Post by User

Neovasc Inc. > No predictions here

<< Previous

Bullboard Posts

Next >>

Comment by Barewoodon May 11, 2018 12:25am

233 Views

Post# 28016245

RE:RE:No predictions here

If a reverse split were to happen now after all the series B warrants and notes were excersized using the cashless alternate net number mechanism, the 1:100 conversion would loook something like this at today's closing price of .065 on the TSX:

Market Cap: 174,953,203 based on 26,915,877x6.50/share

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages